| # | Drug | Count |
|---|---|---|
| 0 | DEFERASIROX | 6 |
| 1 | ECULIZUMAB | 1 |
| 2 | ETANERCEPT | 1 |
| 3 | EVOLOCUMAB | 1 |
| 4 | FINASTERIDE | 1 |
| 5 | FLUOXETINE | 1 |
| 6 | FLUOXETINE HYDROCHLORIDE | 1 |
| 7 | INFLIXIMAB | 1 |
| 8 | INSULIN GLARGINE AND LIXISENATIDE | 1 |
| 9 | PALIPERIDONE PALMITATE | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | INSULIN GLARGINE AND LIXISENATIDE | 1 | 0.0003 |
| 1 | DEFERASIROX | 6 | 0.0002 |
| 2 | PALIPERIDONE PALMITATE | 1 | 0.0000 |
| 3 | TERIFLUNOMIDE | 1 | 0.0000 |
| 4 | ECULIZUMAB | 1 | 0.0000 |
| 5 | FINASTERIDE | 1 | 0.0000 |
| 6 | FLUOXETINE HYDROCHLORIDE | 1 | 0.0000 |
| 7 | EVOLOCUMAB | 1 | 0.0000 |
| 8 | INFLIXIMAB | 1 | 0.0000 |
| 9 | ETANERCEPT | 1 | 0.0000 |
| # | Drug class | Count |
|---|---|---|
| 0 | Iron Chelator [EPC] | 6 |
| 1 | Tumor Necrosis Factor Blocker [EPC] | 2 |
| 2 | 5-alpha Reductase Inhibitor [EPC] | 1 |
| 3 | Complement Inhibitor [EPC] | 1 |
| 4 | GLP-1 Receptor Agonist [EPC] | 1 |
| 5 | Insulin Analog [EPC] | 1 |
| 6 | PCSK9 Inhibitor [EPC] | 1 |
| 7 | Pyrimidine Synthesis Inhibitor [EPC] | 1 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Iron Chelator [EPC] | 6 | 0.0002 |
| 1 | PCSK9 Inhibitor [EPC] | 1 | 0.0000 |
| 2 | Pyrimidine Synthesis Inhibitor [EPC] | 1 | 0.0000 |
| 3 | Complement Inhibitor [EPC] | 1 | 0.0000 |
| 4 | 5-alpha Reductase Inhibitor [EPC] | 1 | 0.0000 |
| 5 | GLP-1 Receptor Agonist [EPC] | 1 | 0.0000 |
| 6 | Insulin Analog [EPC] | 1 | 0.0000 |
| 7 | Tumor Necrosis Factor Blocker [EPC] | 2 | 0.0000 |